Page last updated: 2024-10-31

neostigmine and Demyelinating Diseases

neostigmine has been researched along with Demyelinating Diseases in 3 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mees, DE1
Frederickson, EL1
Aita, JF1
Snyder, DH1
Reichl, W1
Welch, LK1
Appenzeller, O1
Bicknell, JM1

Other Studies

3 other studies available for neostigmine and Demyelinating Diseases

ArticleYear
Anesthesia and the porphyrias.
    Southern medical journal, 1975, Volume: 68, Issue:1

    Topics: 5-Aminolevulinate Synthetase; Acute Disease; Aminolevulinic Acid; Ammonia-Lyases; Anesthesia; Anesth

1975
Myasthenia gravis and multiple sclerosis: an unusual combination of diseases.
    Neurology, 1974, Volume: 24, Issue:1

    Topics: Adult; Brain; Demyelinating Diseases; Diplopia; Edrophonium; Electroencephalography; Female; gamma-G

1974
Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor unit activity.
    Neurology, 1972, Volume: 22, Issue:2

    Topics: Action Potentials; Adult; Calcium; Decamethonium Compounds; Demyelinating Diseases; Edrophonium; Ele

1972